Applied DNA to Report Fiscal 2020 Third Quarter Financial Results After Market Close on August 6, 2020
July 30, 2020
Applied DNA and Takis Report Positive Preclinical Results from LineaDNA™ Vaccine Candidates for COVID-19
July 17, 2020
Applied DNA Appoints New Head of Investor Relations and Corporate Communications
July 15, 2020
Applied DNA Forms Clinical Testing Subsidiary to Maximize Utility of FDA EUA-Approved Linea™ COVID-19 Assay Kit and Expands Utility with Successful EUA Amendment
July 9, 2020
Applied DNA Secures Grant from National Grid Partnered with the New York State MEP to Support Manufacture of COVID-19 Diagnostic Kits and Vaccine Candidates
June 9, 2020
Applied DNA to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27
May 21, 2020
Get Social